Sage Therapeutics Research and Development Expense (TTM) Trends | YCharts

Sage Therapeutics Inc (SAGE)

11.70 -0.31 (-2.58%) USD | NASDAQ | May 17, 16:00

11.70 0.00 (0.00%) After-Hours: 20:00

Research and Development Expense (TTM) Chart

Historical Research and Development Expense (TTM) Data

View and export this data back to 2013. Upgrade now.

Date	Value
March 31, 2024	335.14M
December 31, 2023	356.24M
September 30, 2023	381.20M
June 30, 2023	360.84M
March 31, 2023	340.97M
December 31, 2022	326.16M
September 30, 2022	312.31M
June 30, 2022	314.26M
March 31, 2022	303.13M
December 31, 2021	283.17M
September 30, 2021	289.43M
June 30, 2021	280.01M
March 31, 2021	287.16M
December 31, 2020	292.71M
September 30, 2020	302.26M
June 30, 2020	330.29M
March 31, 2020	346.03M
December 31, 2019	368.82M
September 30, 2019	366.37M
June 30, 2019	339.31M
March 31, 2019	319.24M

Date	Value
December 31, 2018	282.11M
September 30, 2018	244.19M
June 30, 2018	227.43M
March 31, 2018	214.35M
December 31, 2017	210.28M
September 30, 2017	201.39M
June 30, 2017	172.18M
March 31, 2017	142.38M
December 31, 2016	120.76M
September 30, 2016	99.13M
June 30, 2016	87.53M
March 31, 2016	80.04M
December 31, 2015	69.36M
September 30, 2015	57.93M
June 30, 2015	47.05M
March 31, 2015	32.83M
December 31, 2014	24.10M
September 30, 2014	19.67M
June 30, 2014	16.47M
March 31, 2014	15.95M
December 31, 2013	14.36M

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (TTM) Range, Past 5 Years

280.01M

Minimum

Jun 2021

381.20M

Maximum

Sep 2023

325.79M

Average

328.23M

Median

Research and Development Expense (TTM) Benchmarks

Biogen Inc	2.344B
Vanda Pharmaceuticals Inc	78.74M
Ligand Pharmaceuticals Inc	23.84M
ADMA Biologics Inc	2.895M
Axsome Therapeutics Inc	116.98M